These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
165 related items for PubMed ID: 21380990
21. Progesterone for prevention of recurrent preterm birth: impact of gestational age at previous delivery. Spong CY, Meis PJ, Thom EA, Sibai B, Dombrowski MP, Moawad AH, Hauth JC, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S, National Institute of Child Health and Human Development Maternal Fetal Medicine Units Network. Am J Obstet Gynecol; 2005 Sep; 193(3 Pt 2):1127-31. PubMed ID: 16157124 [Abstract] [Full Text] [Related]
22. Does progesterone treatment influence risk factors for recurrent preterm delivery? Meis PJ, Klebanoff M, Dombrowski MP, Sibai BM, Leindecker S, Moawad AH, Northen A, Iams JD, Varner MW, Caritis SN, O'Sullivan MJ, Miodovnik M, Leveno KJ, Conway D, Wapner RJ, Carpenter M, Mercer B, Ramin SM, Thorp JM, Peaceman AM, Gabbe S. Obstet Gynecol; 2005 Sep; 106(3):557-61. PubMed ID: 16135587 [Abstract] [Full Text] [Related]
23. Double-blind randomized trial of progesterone to prevent preterm birth in second-trimester bleeding. Salim R, Hakim M, Zafran N, Nachum Z, Romano S, Garmi G. Acta Obstet Gynecol Scand; 2019 Oct; 98(10):1318-1325. PubMed ID: 31087325 [Abstract] [Full Text] [Related]
24. The value of oral micronized progesterone in the prevention of recurrent spontaneous preterm birth: a randomized controlled trial. Ashoush S, El-Kady O, Al-Hawwary G, Othman A. Acta Obstet Gynecol Scand; 2017 Dec; 96(12):1460-1466. PubMed ID: 28949010 [Abstract] [Full Text] [Related]
25. Progesterone for preterm birth prevention: an evolving intervention. Tita AT, Rouse DJ. Am J Obstet Gynecol; 2009 Mar; 200(3):219-24. PubMed ID: 19254577 [Abstract] [Full Text] [Related]
26. Assessment of sub-endometrial blood flow parameters following dydrogesterone and micronized vaginal progesterone administration in women with idiopathic recurrent miscarriage: a pilot study. Ghosh S, Chattopadhyay R, Goswami S, Chaudhury K, Chakravarty B, Ganesh A. J Obstet Gynaecol Res; 2014 Jul; 40(7):1871-6. PubMed ID: 25056464 [Abstract] [Full Text] [Related]
28. Use of progesterone to prevent preterm birth at a tertiary care center. Bailit JL, Berkowitz R, Thorp JM, Cleary K, Hartmann KE, Mercer BM. J Reprod Med; 2007 Apr; 52(4):280-4. PubMed ID: 17506366 [Abstract] [Full Text] [Related]
29. A randomized controlled trial of intramuscular versus vaginal progesterone for the prevention of recurrent preterm birth. Elimian A, Smith K, Williams M, Knudtson E, Goodman JR, Escobedo MB. Int J Gynaecol Obstet; 2016 Aug; 134(2):169-72. PubMed ID: 27168167 [Abstract] [Full Text] [Related]
31. The risk for preterm labor in women receiving 17 alpha-hydroxyprogesterone caproate prophylaxis for preterm birth prevention. Joy S, Rhea DJ, Istwan NB, Desch CN, Stanziano G. Am J Perinatol; 2010 Apr; 27(4):343-8. PubMed ID: 20013580 [Abstract] [Full Text] [Related]
32. Pharmacokinetics of vaginal progesterone in pregnancy. Boelig RC, Zuppa AF, Kraft WK, Caritis S. Am J Obstet Gynecol; 2019 Sep; 221(3):263.e1-263.e7. PubMed ID: 31211965 [Abstract] [Full Text] [Related]
33. Optimal routes of administration, vehicles and timing of progesterone treatment for inhibition of delivery during pregnancy. Fang D, Moreno M, Garfield RE, Kuon R, Xia H. Eur J Obstet Gynecol Reprod Biol; 2017 Sep; 216():164-168. PubMed ID: 28777967 [Abstract] [Full Text] [Related]